These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23211969)

  • 1. Design, synthesis and characterization of novel 1,2-benzisothiazol-3(2H)-one and 1,3,4-oxadiazole hybrid derivatives: potent inhibitors of Dengue and West Nile virus NS2B/NS3 proteases.
    Lai H; Dou D; Aravapalli S; Teramoto T; Lushington GH; Mwania TM; Alliston KR; Eichhorn DM; Padmanabhan R; Groutas WC
    Bioorg Med Chem; 2013 Jan; 21(1):102-13. PubMed ID: 23211969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Dengue virus and West Nile virus proteases by click chemistry-derived benz[d]isothiazol-3(2H)-one derivatives.
    Tiew KC; Dou D; Teramoto T; Lai H; Alliston KR; Lushington GH; Padmanabhan R; Groutas WC
    Bioorg Med Chem; 2012 Feb; 20(3):1213-21. PubMed ID: 22249124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors of Dengue virus and West Nile virus proteases based on the aminobenzamide scaffold.
    Aravapalli S; Lai H; Teramoto T; Alliston KR; Lushington GH; Ferguson EL; Padmanabhan R; Groutas WC
    Bioorg Med Chem; 2012 Jul; 20(13):4140-8. PubMed ID: 22632792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arylcyanoacrylamides as inhibitors of the Dengue and West Nile virus proteases.
    Nitsche C; Steuer C; Klein CD
    Bioorg Med Chem; 2011 Dec; 19(24):7318-37. PubMed ID: 22094280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of NS2B-NS3 protease and furin inhibition on West Nile and Dengue virus replication.
    Kouretova J; Hammamy MZ; Epp A; Hardes K; Kallis S; Zhang L; Hilgenfeld R; Bartenschlager R; Steinmetzer T
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):712-721. PubMed ID: 28385094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tripeptide inhibitors of dengue and West Nile virus NS2B-NS3 protease.
    Schüller A; Yin Z; Brian Chia CS; Doan DN; Kim HK; Shang L; Loh TP; Hill J; Vasudevan SG
    Antiviral Res; 2011 Oct; 92(1):96-101. PubMed ID: 21763725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A FRET-based assay for the discovery of West Nile Virus NS2B-NS3 protease inhibitors.
    Adamek RN; Maniquis RV; Khakoo S; Bridges MD; Salzameda NT
    Bioorg Med Chem Lett; 2013 Sep; 23(17):4848-50. PubMed ID: 23886689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of Nanomolar Dengue and West Nile Virus Protease Inhibitors Containing a 4-Benzyloxyphenylglycine Residue.
    Behnam MA; Graf D; Bartenschlager R; Zlotos DP; Klein CD
    J Med Chem; 2015 Dec; 58(23):9354-70. PubMed ID: 26562070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput screening for the identification of small-molecule inhibitors of the flaviviral protease.
    Balasubramanian A; Manzano M; Teramoto T; Pilankatta R; Padmanabhan R
    Antiviral Res; 2016 Oct; 134():6-16. PubMed ID: 27539384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small molecule pan-dengue and West Nile virus NS3 protease inhibitors.
    Cregar-Hernandez L; Jiao GS; Johnson AT; Lehrer AT; Wong TA; Margosiak SA
    Antivir Chem Chemother; 2011 May; 21(5):209-17. PubMed ID: 21566267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual inhibitors of the dengue and West Nile virus NS2B-NS3 proteases: Synthesis, biological evaluation and docking studies of novel peptide-hybrids.
    Bastos Lima A; Behnam MA; El Sherif Y; Nitsche C; Vechi SM; Klein CD
    Bioorg Med Chem; 2015 Sep; 23(17):5748-55. PubMed ID: 26233795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploiting the unique features of Zika and Dengue proteases for inhibitor design.
    Majerová T; Novotný P; Krýsová E; Konvalinka J
    Biochimie; 2019 Nov; 166():132-141. PubMed ID: 31077760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-guided fragment-based in silico drug design of dengue protease inhibitors.
    Knehans T; Schüller A; Doan DN; Nacro K; Hill J; Güntert P; Madhusudhan MS; Weil T; Vasudevan SG
    J Comput Aided Mol Des; 2011 Mar; 25(3):263-74. PubMed ID: 21344277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling of flaviviral NS2B-NS3 protease specificity provides a structural basis for the development of selective chemical tools that differentiate Dengue from Zika and West Nile viruses.
    Rut W; Groborz K; Zhang L; Modrzycka S; Poreba M; Hilgenfeld R; Drag M
    Antiviral Res; 2020 Mar; 175():104731. PubMed ID: 32014497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure activity relationship (SAR) and quantitative structure activity relationship (QSAR) studies showed plant flavonoids as potential inhibitors of dengue NS2B-NS3 protease.
    Sarwar MW; Riaz A; Dilshad SMR; Al-Qahtani A; Nawaz-Ul-Rehman MS; Mubin M
    BMC Struct Biol; 2018 Apr; 18(1):6. PubMed ID: 29673347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breathing new life into West Nile virus therapeutics; discovery and study of zafirlukast as an NS2B-NS3 protease inhibitor.
    Martinez AA; Espinosa BA; Adamek RN; Thomas BA; Chau J; Gonzalez E; Keppetipola N; Salzameda NT
    Eur J Med Chem; 2018 Sep; 157():1202-1213. PubMed ID: 30193218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and in vitro evaluation of West Nile virus protease inhibitors based on the 2-{6-[2-(5-phenyl-4H-{1,2,4]triazol-3-ylsulfanyl)acetylamino]benzothiazol-2-ylsulfanyl}acetamide scaffold.
    Samanta S; Lim TL; Lam Y
    ChemMedChem; 2013 Jun; 8(6):994-1001. PubMed ID: 23619931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro evaluation of novel inhibitors against the NS2B-NS3 protease of dengue fever virus type 4.
    Nguyen TT; Lee S; Wang HK; Chen HY; Wu YT; Lin SC; Kim DW; Kim D
    Molecules; 2013 Dec; 18(12):15600-12. PubMed ID: 24352016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proline-Based Allosteric Inhibitors of Zika and Dengue Virus NS2B/NS3 Proteases.
    Millies B; von Hammerstein F; Gellert A; Hammerschmidt S; Barthels F; Göppel U; Immerheiser M; Elgner F; Jung N; Basic M; Kersten C; Kiefer W; Bodem J; Hildt E; Windbergs M; Hellmich UA; Schirmeister T
    J Med Chem; 2019 Dec; 62(24):11359-11382. PubMed ID: 31769670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery, synthesis, and in vitro evaluation of West Nile virus protease inhibitors based on the 9,10-dihydro-3H,4aH-1,3,9,10a-tetraazaphenanthren-4-one scaffold.
    Samanta S; Cui T; Lam Y
    ChemMedChem; 2012 Jul; 7(7):1210-6. PubMed ID: 22550001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.